Treatment with an SLC12A1 antagonist inhibits tumorigenesis in a subset of hepatocellular carcinomas

A central aim in cancer research is to identify genes with altered expression patterns in tumor specimens and their potential role in tumorigenesis. Most types of tumors, including hepatocellular carcinoma (HCC), are heterogeneous in terms of genotype and phenotype. Thus, traditional analytical meth...

Descripción completa

Detalles Bibliográficos
Autores principales: Teng, Fei, Guo, Meng, Liu, Fang, Wang, Ce, Dong, Jiayong, Zhang, Lei, Zou, You, Chen, Rui, Sun, Keyan, Fu, Hong, Fu, Zhiren, Guo, Wenyuan, Ding, Guoshan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5288206/
https://www.ncbi.nlm.nih.gov/pubmed/27447551
http://dx.doi.org/10.18632/oncotarget.10670

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5288206/
https://www.ncbi.nlm.nih.gov/pubmed/27447551
http://dx.doi.org/10.18632/oncotarget.10670

Ejemplares similares